Entrenched in academia, chemist Jacob Berlin spent a decade making small molecules to treat the world’s biggest diseases. He wondered: How can this process...
Medical device startup General Prognostics announced it raised $3.25 million in seed funding this week to launch a wearable monitoring device that could noninvasively...
Torrent Pharmaceuticals, a generic drug maker, is set to acquire dermatology startup Curatio Healthcare for $245 million, The Economic Times reported on Tuesday.
The deal,...
Where the data goes, investors will follow.
In February, Charlottesville, Virginia-based Rivus Pharmaceuticals announced optimistic news: It saw positive results in clinical trials for a drug...
CytoReason and Pfizer are re-upping their three-year partnership with a fresh, ambitious goal.
On Tuesday, the companies announced they will renew their partnership with a...
It looks like the hype is over for psychedelics.
After four years of optimistic funding fueled by strong research from top-tier universities, the novelty surrounding...
Biomedical platform Galvanize Therapeutics announced on Thursday it raised $100 million in Series B financing led by Fidelity Management and Research Company, with additional...
